Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Imaging
MedTech
FDA approves Pixclara, the first FET-PET drug for brain cancer
The FDA has signed off on the first-ever glioma drug imaging diagnostic more than a year after it initially rejected the med.
Ben Adams
Sep 15, 2026 7:40am
RadNet snaps up Gleamer for €215M upfront
Mar 4, 2026 8:30am
Cleveland Clinic, Canon collab on imaging research center
Dec 1, 2023 10:12am
GE HealthCare, J&J's DePuy Synthes forge 3D imaging partnership
Jun 22, 2023 12:05pm
Philips taps AWS to put imaging tools in the cloud
Apr 17, 2023 12:08pm
GE HealthCare, Sinopharm plan imaging-focused joint venture
Feb 27, 2023 11:11am
